{"id":"W2921616646","doi":"10.1136/ejhpharm-2019-eahpconf.49","title":"2SPD-009 Analysis of olaparib and talazoparib as possible therapeutic alternatives in advanced breast cancer and a germline BRCA mutation","year":2019,"lang":"en","type":"article","venue":"","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Universidad de Sevilla","keywords":"Eribulin; Olaparib; Medicine; Vinorelbine; Oncology; Internal medicine; Taxane; Capecitabine; BRCA mutation; Breast cancer; Metastatic breast cancer; Anthracycline; Population; Cancer; Chemotherapy; Colorectal cancer; Genetics","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009184903,0.0008140892,0.003784852,0.002316152,0.0002589651,0.001744422,0.0006656554,0.001207815,0.02657279],"category_scores_gemma":[0.01598099,0.0002916307,0.01075383,0.002519807,0.0005188455,0.0009436453,0.00094592,0.001181142,0.001003835],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001228777,"about_ca_system_score_gemma":0.001779725,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006669276,"about_ca_topic_score_gemma":0.001702106,"domain_scores_codex":[0.9922466,0.005212665,0.001041031,0.000470185,0.0007572832,0.0002721828],"domain_scores_gemma":[0.9862838,0.01012071,0.001942561,0.000396797,0.0007083662,0.0005477488],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6673719,0.001529841,0.01540789,0.08443168,0.123931,0.0008080499,0.0002188616,0.002213665,0.005042871,0.002637115,0.003691974,0.0927152],"study_design_scores_gemma":[0.3088183,0.11232,0.08455567,0.01043484,0.4006549,0.001546928,0.0006671012,0.004425035,0.003322225,0.005173692,0.06788915,0.0001920836],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6664525,0.2466662,0.006080486,0.003208539,0.001260413,0.01263925,0.04228724,0.0002018299,0.02120352],"genre_scores_gemma":[0.9545366,0.02109219,0.003686141,0.001251,0.0004220228,0.004361809,0.01070992,0.00005267677,0.003887638],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02657279,"threshold_uncertainty_score":0.08889484,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01038479930307852,"score_gpt":0.3308714411877353,"score_spread":0.3204866418846568,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}